elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33621041-56BCD804-29C5-4333-B92B-A7FABF722F0D
Q33621041-56BCD804-29C5-4333-B92B-A7FABF722F0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33621041-56BCD804-29C5-4333-B92B-A7FABF722F0D
Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape.
P2860
Q33621041-56BCD804-29C5-4333-B92B-A7FABF722F0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33621041-56BCD804-29C5-4333-B92B-A7FABF722F0D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c1ebf8a707f7fe7ebdf1689e1057f552c848b2ef
P2860
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.